Actuate Therapeutics Inc (ACTU)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,626 | -22,228 | -17,674 | -12,266 | -6,317 |
| Accounts payable and accrued liabilities | -323 | -513 | -698 | 1,130 | 622 |
| Other Working Capital | -892 | -3,045 | -2,317 | 759 | 568 |
| Other Operating Activity | 1,823 | 6,579 | 5,218 | 1,584 | 508 |
| Operating Cash Flow | $-5,017 | $-19,206 | $-15,470 | $-8,793 | $-4,619 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 520 | 24,027 | 24,027 | 6,819 | N/A |
| Other Financing Activity | -528 | -303 | -274 | -175 | -134 |
| Financing Cash Flow | $-8 | $23,724 | $23,753 | $6,644 | $-134 |
| Beginning Cash Position | 13,159 | 8,642 | 8,642 | 8,642 | 8,642 |
| End Cash Position | 8,134 | 13,159 | 16,925 | 6,493 | 3,889 |
| Net Cash Flow | $-5,025 | $4,518 | $8,283 | $-2,149 | $-4,752 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,017 | -19,206 | -15,470 | -8,793 | -4,619 |
| Free Cash Flow | -5,017 | -19,206 | -15,470 | -8,793 | -4,619 |